Eli Lilly, Walmart partner to expand direct-to-consumer pricing for Zepbound
Walmart will serve as the first in-store pickup pharmacy for LillyDirect’s self-pay single-dose vials.
Lilly
Lilly to offer all approved doses of Zepbound (tirzepatide) single-dose vials through LillyDirect Self Pay Pharmacy Solutions
With the addition of 12.5 mg and 15 mg vials, all approved doses of Zepbound will be available in single-dose vials for $499/month or less, regardless of insurance status, under Zepbound Self Pay Journey Program.
Eli Lilly says new GLP-1 pill for diabetes and weight loss effective in study, will seek FDA approval
Orforglipron is the first small molecule GLP-1 to successfully complete a Phase 3 trial, lowering A1C by an average of 1.3% to 1.6% across doses.